Burton's Agammaglobulinemia and COVID-19.
Burton's Agammaglobulinemia and COVID-19.
复制标题
DOI：
10.7759/cureus.11701
复制
发表时间：
2020-11-25
期刊：
影响因子：
--
通讯作者：
Howell D
中科院分区：
文献类型：
--
作者：
Hovey JG;Tolbert D;Howell D
在SARS-CoV-2全球大流行期间，许多患有并发症的患者被认为是发病率和死亡率高的风险;然而，那些免疫缺陷的患者患重病的风险更高。在这篇文章中，我们提出了一个26岁的男性与X-连锁无丙种球蛋白血症的历史谁提出了到医院发热和寒战后，暴露于SARS-CoV-2阳性个人。患者住院时间较长，但接受恢复期血浆治疗后症状迅速改善。该病例强调了严重免疫球蛋白缺乏症患者的临床病程，以及合并无丙种球蛋白血症和COVID-19患者的可能治疗方法。
During the SARS-CoV-2 global pandemic, many patients who have co-morbid conditions are considered high risk for morbidity and mortality; however, those who are immunodeficient are at higher risk of becoming seriously ill. In this article, we present a 26-year old male with a history of X-linked agammaglobulinemia who presented to the hospital with fever and chills after exposure to a SARS-CoV-2 positive individual. The patient had a prolonged course in the hospital, but his symptoms improved quickly after receiving convalescent plasma. This case highlights the clinical course of a patient with severe immunoglobulin deficiency and a possible treatment approach for patients with concomitant agammaglobulinemia and COVID-19.
登录
查看更多内容
影响因子：
64.5
作者：
TSUKADA, S;SAFFRAN, DC;WITTE, ON
通讯作者：
WITTE, ON
影响因子：
1.6
作者：
Winkelstein, Jerry A.;Marino, Mary C.;Ochs, Hans D.
通讯作者：
Ochs, Hans D.
影响因子：
4.4
作者：
Soresina, Annarosa;Moratto, Daniele;Badolato, Raffaele
通讯作者：
Badolato, Raffaele
影响因子：
64.8
作者：
VETRIE, D;VORECHOVSKY, I;BENTLEY, DR
通讯作者：
BENTLEY, DR